JW Therapeutics competitorsClear all

Eutilex's top competitors include Foghorn Therapeutics.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Eutilex
Eutilex
Eutilex ((주)유틸렉스) is a biotech company developing anti-tumor T-cell therapy and antibody therapeutics based on its proprietary immunotherapy technology.
Foghorn Therapeutics
Foghorn Therapeutics
Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.
Founding Date
Founding Date
2015
Founding Date
2016
Type
Type
Public
Type
Public
Tags
Locations
Locations
KR HQ
Locations
Cambridge, US HQ
Cambridge, US
Employees
Employees
108
Employees
85

Financial

Revenue (est.)
Revenue (est.)
₩2b (FY, 2020)
Revenue (est.)
$430k (FY, 2020)
Net income
Net income
(₩28.8b) (FY, 2020)
Net income
($68.8m) (FY, 2020)

Funding

Total funding raised
Total funding raised
$ 18.9m
Total funding raised
$ 50m
For sources of this data, please see the company profile

View company profiles

Foghorn Therapeutics
HQ
Cambridge, US
Employees
85

Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors.

View company